Dermatology Book

http://www.fpnotebook.com/

Pemphigus Vulgaris

Aka: Pemphigus Vulgaris
  1. See Also
    1. Bullous Disease
    2. Pemphigus
  2. Epidemiology
    1. Incidence: 0.5 to 3.2 cases per 100,000 (U.S.)
    2. Higher Incidence in Ashkenazi jews
    3. Mean age of onset: 40 to 60 years old
    4. Men and women are affected equally
  3. Definition
    1. Most common, severe and deeper form of Pemphigus
  4. Risk Factors
    1. Ashkenazi jewish descent
    2. Autoimmune condition (e.g. SLE, Rheumatoid Arthritis, Myasthenia Gravis)
    3. Triggers
      1. See medications below
      2. Burn Injury
      3. Infections
  5. Pathophysiology
    1. IgG against Keratinocyte cell surface molecules (desmoglein 1 and 3) in skin and mucosa
      1. Antibody binding results in Acantholysis (loss of cell to cell adhesion)
    2. May be unmasked by certain medications (e.g. Penicillin, NSAIDs, ACE Inhibitors, Pyrazolones)
      1. See Drug-Triggered Pemphigus
  6. Symptoms
    1. Painful, often burning lesions (may be pruritic)
    2. Oral symptoms with mucosal involvement
      1. Dysphagia
      2. Hoarseness
      3. Epistaxis
    3. Constitutional symptoms
      1. Weakness
      2. Malaise
  7. Signs
    1. Mucosal sites of involvement
      1. Painful Gingival erosions (50-70% of patients)
      2. May precede skin bullae by months
      3. Conjunctiva and esophagus may also be involved
    2. Flaccid bullae (difficult to see due to flaccidity)
      1. Clear fluid filled Blisters that easily rupture, developing into painful erosions
      2. Blisters overly an erythematous base
      3. Nikolsky Sign positive
    3. Painful erosions (most common skin finding)
      1. May bleed easily
      2. Crusting is often present
      3. Lesions are painful rather than pruritic (contrast with Bullous Pemphigoid)
    4. Skin Sites of involvement
      1. Face
      2. Scalp
      3. Upper body
      4. Intertriginous areas (axillae, groin)
      5. Umbilicus
      6. Nails (Subungual Hematoma, Chronic Paronychia)
  8. Labs
    1. Biopsy of bulla margin
      1. Suprabasilar Blister (above Basal Cell Layer)
      2. Acantholysis
      3. Rounded basal cells appear as row of tombstones
      4. Eosinophilic infiltrates
    2. Direct Immunofluorescence
      1. Intercellular deposits of IgG and C3 on Keratinocytes
  9. Course
    1. Onset on Oral Mucosa
    2. Skin lesions follow Oral Lesions by months
    3. Localized skin involvement for 6-12 months
    4. Generalized involvement then ensues
  10. Associated Conditions
    1. Thymoma (and Myasthenia Gravis)
    2. Possible complications of immunosuppressive therapy
      1. Kaposi's Sarcoma
      2. Lymphoreticular malignancy
  11. Variants
    1. Pemphigus Vegetans (Familial Benign Pemphigus)
  12. Management: Immunosuppressive Therapy
    1. Disposition
      1. Most patients are treated out of the hospital
      2. Admit patients with extensive bullae and erosions for IV fluids and electrolyte management
    2. Prednisone 1 mg/kg/day
      1. Reduce dose by 50% when no new Blister formation
      2. Gradually taper to minimum effective dose
      3. Topical Corticosteroids may also be used as an adjunct
    3. Adjunctive immunosuppressive drugs
      1. Methotrexate
      2. Azathioprine (Imuran)
      3. Cyclophosphamide (Cytoxan)
      4. Mycophenolate mofetil (Cellcept)
    4. Other measures in severe cases
      1. Plasmapheresis
  13. Complications
    1. Secondary infection (due to immunosuppressive therapy)
  14. Prognosis
    1. Mortality highest in first few years (up to 10%)
      1. Complications of Corticosteroids
  15. References
    1. Long (2016) Crit Dec Emerg Med 30(7):3-10
    2. Cotran (1999) Robbins Pathology, p. 1202
    3. Bickle (2002) Am Fam Physician 65(9):1861-70 [PubMed]
    4. Cotell (2000) Am J Emerg Med 18(3):288-99 [PubMed]
    5. Rye (1997) Am Fam Physician 55(8): 2709-18 [PubMed]

Pemphigus Vulgaris (C0030809)

Definition (NCI) An autoimmune blistering disorder. It is characterized by the presence of painful blisters and erosions in the skin and mucous membranes.
Concepts Disease or Syndrome (T047)
MSH D010392
ICD10 L10.0
SnomedCT 49420001
Dutch pemphigus vulgaris, pemphigus; vulgaris, vulgaris; pemphigus, Pemphigus vulgaris
Portuguese Pênfigo vulgar, Pênfigo Vulgar
Spanish Pénfigo vulgar, Pénfigo Vulgar, pénfigo vulgar (trastorno), pénfigo vulgar
Japanese 尋常性天疱瘡, ジンジョウセイテンポウソウ
French Pemphigus vulgaire, Pemphigus vulgaris
German Pemphigus vulgaris
English pemphigus vulgaris, pemphigus vulgaris (diagnosis), pemphigus pv vulgaris, Pemphigus vulgaris, PV - Pemphigus vulgaris, Pemphigus vulgaris (disorder), pemphigus; vulgaris, vulgaris; pemphigus, Pemphigus Vulgaris, Pemphigus, vulgaris
Czech Pemphigus vulgaris
Korean 보통 천포창
Hungarian Pemphigus vulgaris
Italian Pemfigo volgare
Norwegian Pemphigus vulgaris
Sources
Derived from the NIH UMLS (Unified Medical Language System)


You are currently viewing the original 'fpnotebook.com\legacy' version of this website. Internet Explorer 8.0 and older will automatically be redirected to this legacy version.

If you are using a modern web browser, you may instead navigate to the newer desktop version of fpnotebook. Another, mobile version is also available which should function on both newer and older web browsers.

Please Contact Me as you run across problems with any of these versions on the website.

Navigation Tree